Gastroenterologia Japonica

, Volume 28, Supplement 5, pp 32–36 | Cite as

Epidemiology of hepatitis C virus infection in Australia

  • Geoffrey C. Farrell
  • Martin Weltman
  • Julia Dingley
  • Rita Lin
Serology and Epidemiology HCV


Chronic Active Hepatitis Autoimmune Chronic Active Hepatitis Parenteral Risk Factor Intrafamilial Transmission Chronic Active Hepati 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lucas CR, Gust ID, McCrorie M, et al. Epidemiology and clinical features of non-A non-B hepatitis in Melbourne. In: Szmuness W, Alter HJ, Maynard JE eds. Viral Hepatitis. Philadelphia: Franklin Institute Press. 1982;70.Google Scholar
  2. 2.
    Cossart YE, Kirsch S, Ismay SL. Post-transfusion hepatitis in Australia. Lancet 1982;l: 208–213.CrossRefGoogle Scholar
  3. 3.
    Lin R, Yatsuhashi H, Yano M, et al. Hepatitis C as the cause of chronic non-A, non-B hepatitis: high sensitivity of simultaneous measurement of core and non-structural antibodies. J Gastroenterol Hepatol 1992;7: 459–462.PubMedCrossRefGoogle Scholar
  4. 4.
    Archer GT, Buring ML, Clark B, et al. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992;157: 225–227.PubMedGoogle Scholar
  5. 5.
    Schoeman MN, Liddle C, Bilous M, et al. Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression. Aust NZ J Med 1990;20: 56–62.Google Scholar
  6. 6.
    Lin R, Farrell GC, and the Australian Hepatitis C Study Group. Alpha-interferon 2b in the treatment of chronic active hepatitis C: interim report of the first multicentre Austrialian trial. J Gastroenterol Hepatol 1992;7: A2. (abstr)Google Scholar
  7. 7.
    Lin R, Schoeman MN, Craig PI, et al. Can the response to interferon treatment be predicted in patients with chronic active hepatitis C? Aust NZ J Med 1991;21: 387–392.Google Scholar
  8. 8.
    Kaldor JM, Archer GT, Buring ML, et al. Risk factors for hepatitis C virus infection in blood donors: a case-control study. Med J Aust 1992;157: 227–230.PubMedGoogle Scholar
  9. 9.
    Bell J, Batey RG, Farrell GC, et al. Hepatitis C virus in intravenous drug users. Med J Aust 1990;153: 274–276.PubMedGoogle Scholar
  10. 10.
    Fairley CK, Leslie DE, Nicholson S, et al. Epidemiology and hepatitis C in Victoria. Med J Aust 1990;153: 271–273.PubMedGoogle Scholar
  11. 11.
    Roger SD, Crewe E, Cunningham A, et al. Hepatitis C virus infection in haemodialysis patients. Aust NZ J Med 1991;21: 22–24.Google Scholar
  12. 12.
    Oshita M, Hayashi N, Kasahara A, et al. Intrafamilial transmission of Hepatitis C virus. Hepatology 1992;16: 582 (abstr).CrossRefGoogle Scholar
  13. 13.
    Inokuchi K, Yatsuhahsi H, Matsumura N, et al. Serological investigation of intrafamilial transmissions of HCV. Proceedings of the APASL Meeting, Soeul, 1992 (abstr).Google Scholar
  14. 14.
    McGuiness P, Lien A, Tulloch R, et al. Prevalence of serum hepatitis C virus RNA in anti-HCV seropositive blood donors: correlation with ALT abnormalities. J Gastroenterol Hepatol 1992;7: A2 (abstr).Google Scholar
  15. 15.
    Mackay IR. Autoimmune hepatitis: lifting the seventh veil. J Gastroenterol Hepatol 1988;3: 169–175.CrossRefGoogle Scholar
  16. 16.
    Liddle C, Crewe EB, Swanson NR, et al. Does hepatitis C virus play a role in “non-viral” chronic liver disease? Med J Aust 1990;153: 265–271.PubMedGoogle Scholar
  17. 17.
    Hollinger FB, Lin HJ. Community-acquired hepatitis C virus infection. Gastroenterology 1992;102: 1426–1429.PubMedGoogle Scholar
  18. 18.
    Everhart JE, Di Bisceglie AM, Murray LM, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990;112: 544–545.PubMedGoogle Scholar
  19. 19.
    Inoue Y, Miyamura T, Unayama T, et al. Maternal transfer of HCV. Nature 1991;353: 609.PubMedCrossRefGoogle Scholar
  20. 20.
    Manns MP, Griffin KJ, Sullivan KF, et al. LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase. J Clin Invest 1991;88: 1370–1378.PubMedCrossRefGoogle Scholar
  21. 21.
    Ma Y, Lenzi M, Gäken J, et al. The target antigen of liver kidney microsomal antibody is different in type II autoimmune chronic active hepatitis and chronic hepatitis C virus infection. Hepatology 1992;16: 563 (abstr).Google Scholar

Copyright information

© The Japanese Society of Gastroenterology 1993

Authors and Affiliations

  • Geoffrey C. Farrell
    • 1
    • 2
  • Martin Weltman
    • 1
    • 2
  • Julia Dingley
    • 1
    • 2
  • Rita Lin
    • 1
    • 2
  1. 1.Department of MedicineUniversity of SydneyWesmeadAustralia
  2. 2.Department of Gastroenterology and HepatologyWestmead HospitalWesmeadAustralia

Personalised recommendations